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Abstract We investigated the ability of tBid (truncated form of
Bid) to bind and permeabilize the liposomes (large unilamellar
vesicles, LUVs) and release £uorescent marker molecules (£uo-
rescein-isothiocyanate-conjugated dextrans, FITC-dextrans) of
various molecular diameters (FD-20, FD-70, FD-250S) from
LUVs. Obtained data showed that tBid was more e⁄cient in
promoting leakage of FITC-dextrans from LUVs composed of
cardiolipin and dioleoylphosphatidylcholine (DOPC) than LUVs
made of dioleoylphosphatidic acid or dioleoylphosphatidylgly-
cerol and DOPC. The leakage e⁄ciency was reduced with in-
creasing amount of dioleoylphosphatidylethanolamine or dielai-
doylphosphatidylethanolamine. Phospholipid monolayer assay
and £uorescence quenching measurements revealed that tBid
inserted deeply into the hydrophobic acyl chain of acidic phos-
pholipids. Taking into account the tBid three-dimensional struc-
ture, we propose that tBid could penetrate into the hydrophobic
core of membrane, resulting in the leakage of entrapped content
from LUVs via a pore-forming mechanism.
4 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Mitochondria are viewed as one of the most pivotal sensors
and ampli¢ers in an apoptotic process by releasing apopto-
genic proteins including cytochrome c, AIF (apoptosis-induc-
ing factor), Smac/DIABLO and endonuclease G [1,2]. It has
been proven that the release of these proteins is mainly regu-
lated by Bcl-2 protein family members, which constitute a
critical checkpoint in the apoptotic cascade [3,4]. Members
of this family include both pro- and anti-apoptotic molecules,
which are characterized by the presence of up to four con-
served regions termed Bcl-2 homology (BH) domains (BH1^
BH4). Bid is an abundant proapoptotic protein of the Bcl-2
family that shares its sequence homology only within the BH3
amphipathic K-helical region. Emerging evidence indicates
that Bid is involved in various pathways of apoptosis that
interplay the activation of caspases with mitochondrial dys-
function [5,6]. Full-length Bid is usually localized in the cyto-
solic fraction of living cells and activated through proteolytic
cleavage by caspase 8 following treatment with TNFK or anti-
Fas. After the cleavage, the truncated product, tBid, trans-
locates to the mitochondria and facilitates the release of cy-
tochrome c, as well as other proteins resident in the intermem-
brane space.
tBid might serve as a death ligand to induce the release of
cytochrome c from mitochondria by promoting conformation-
al change of other proteins, such as Bax or Bak [7,8]. Alter-
natively, it is also conceivable that tBid alone may be capable
of destabilizing lipid membranes in vitro [9,10]. Studies using
model membrane systems reveal that tBid can form ion chan-
nels in planar bilayers [11] and thus lead to the leakage of the
entrapped small molecules, such as 5,6-carboxy£uorescein or
ANTS/DPX, as well as large molecules such as cytochrome
c or trypsin, from phospholipid vesicles [9,10,12,13]. These
results propose that Bid can function on its own as a down-
stream e¡ector directly on the mitochondrial outer membrane.
Of note, studies with recombinant Bid indicate that protein^
lipid interactions leading to membrane permeation play a ma-
jor role on its activity. It has been reported that tBid may
speci¢cally interact with cardiolipin, a negatively charged lipid
characteristically located on the inner mitochondrial mem-
brane as well as in the inner^outer membrane contact sites
[14]. Moreover, recent evidence suggests that Bid has an in-
trinsic capacity of binding and exchanging membrane lipids,
which is similar to plant lipid transfer proteins [15,16]. This
unique similarity of Bid with unrelated proteins suggests com-
mon interactions with lipids. The biochemical mechanism by
which Bid performs its function on mitochondria remains
uncertain. The three-dimensional structure of Bid shows a
bundle of eight K-helices with two central predominantly hy-
drophobic helices forming the core of the molecule [17,18],
which is reminiscent of pore-forming regions in the bacterial
toxins of diphtheria toxin fragment B and colicin. Recently,
recombinant tBid has been reported to form oligomers in the
presence of non-ionic detergents or mitochondrial lipids [19].
These data lend credence to the hypothesis that tBid oligo-
mers may form pores in the mitochondrial membranes.
Many studies have revealed that membrane permeation by
amphipathic K-helical peptides occurs via either a pore-form-
ing barrel stave mechanism or a non-pore carpet-like mecha-
nism [20]. By using model membrane systems to determine the
possible mechanism that tBid involves in, we detected in detail
the abilities of tBid to interact with phospholipid membranes
and to induce the leakage of £uorescein-isothiocyanate-con-
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jugated dextrans (FITC-dextrans) with various molecular di-
ameters from large unilamellar vesicles (LUVs) of di¡erent
phospholipid compositions. In light of these results, we tenta-
tively postulated a pore-forming mechanism by which tBid
permeates the phospholipid membranes and induces the leak-
age of encapsulated content from LUVs. This may represent
an alternative mechanism of tBid for inducing mitochondrial
dysfunction and apoptosis.
2. Materials and methods
2.1. Materials
All chemical reagents were of the highest purity available commer-
cially. 1,2-Dioleoyl-sn-glycero-3-phosphate (DOPA), 1,2-dioleoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (DOPG), 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-glycero-3-phospho-
choline (DOPC), 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine
(DEPE), 1,1P,2,2P-tetraoleoyl cardiolipin (CL) and 1-palmitoyl-2-
stearoyl-(12-doxyl)-sn-glycero-3-phosphocholine (12-DPC) were pur-
chased from Avanti Polar Lipids (Alabaster, AL, USA). HEPES,
lubrol PX, FITC-dextrans: FD-20 (molecular weight (MW)=21 200
Da), FD-70 (MW=71 600 Da), FD-250S (MW=282 000 Da) were
products of Sigma (St. Louis, MO, USA). N-(1-pyrenyl) maleimide
(PM) was obtained from Molecular Probes (Junction City, OR,
USA).
2.2. Expression and puri¢cation of recombinant proteins
Murine Bid expression plasmid was kindly provided by Dr. Bruno
Antonsson, Serono Pharmaceutical Research Institute, Switzerland.
Caspase 8 expression plasmid was kindly provided by Dr. Xiaodong
Wang, Southwestern Medical Center in Dallas, TX, USA. The plas-
mids for expression of Bid and caspase 8 were separately transformed
into bacterial BL21(DE3) cells. Then the recombinant proteins were
puri¢ed from the cell lysate using nickel a⁄nity column (Qiagen,
USA), and Bio-scale Q5 column (Bio-Rad, USA) was used for further
puri¢cation. tBid was obtained by adding 1/50 (v/v) caspase 8 to the
full-length Bid, then incubating overnight at 4‡C. The cleavage prod-
uct containing N- and C-terminal fragments can not be separated
because the dissociation normally requires micellar concentrations of
non-ionic detergents. To avoid the possible e¡ect of detergent, the
mixture of the two fragments was used for assays since it has com-
parable activity to the isolated C-terminal fragment [9].
2.3. Preparation of liposomes
LUVs encapsulated with di¡erent FITC-dextrans (FD-20, FD-70,
FD-250S) were prepared. 2.5 ml diethyl ether and 0.5 ml HEPES
bu¡er (10 mM HEPES, pH 7.4, 50 mM NaCl, 0.2 mM ethylenedi-
amine tetraacetic acid (EDTA)) containing FITC-dextrans (5 mg/ml)
were added to a dry lipid ¢lm of 5 Wmol indicated phospholipids.
After sonication for 20 min at 4‡C with a bath sonicator, and evap-
oration of ether under reduced pressure, the vesicles were dialyzed
overnight at 4‡C in HEPES bu¡er. Small unilamellar vesicles
(SUVs) were prepared by sonicating in HEPES bu¡er on a sonicator
at 4‡C under nitrogen purge. After sonication, the solution was cen-
trifuged at 100 000Ug for 30 min on a Beckman TL-100 ultracentri-
fuge to eliminate the multilayer liposomes.
The phospholipid concentration was determined by perchloric acid
digestion [21].
2.4. Assay for leakage of liposomal contents
The leakage assay was performed as the methods described in [22].
LUVs containing FITC-dextrans were prepared by reverse-phase
evaporation, and separated from extravesicular FITC-dextrans by
washing. Following incubation of increasing amounts of tBid with
100 WM LUVs in 100 Wl of HEPES bu¡er at 30‡C for 30 min, the
vesicles were sedimented by centrifugation (25 min, 35 000 rpm, 4‡C).
Half of the supernatant (S) was sampled out, to which, and to the
remainder (R) in the centrifugation tube as well, 350 Wl HEPES bu¡er
containing 0.1% lubrol PX was added to dilute and dissolve the sam-
ples. The control followed the same procedure except for the addition
of bu¡er instead of protein. FITC-dextrans contained in the two parts
of the solution were quanti¢ed using a Hitachi F-4010 spectro£uo-
rometer, and the £uorescence intensity corrected for self-quenching
according to the standard curve of £uorescence versus FITC-dextrans.
FITC-dextrans were excited at 497 nm and emission at 520 nm was
recorded with bandwiths of 5 nm for both excitation and emission.
The percentage of leakage, therefore, was determined by
leakage ð%Þ ¼ 2US
SþR3B
 
U100
where B is the leakage extent of the control.
2.5. Insertion of tBid into phospholipid monolayer
A ¢lm balance, type Han-2000, designed and made in our labora-
tory was used to study membrane insertion ability of proteins. Brie£y,
3 ml HEPES bu¡er was added into the mini-trough as a subphase
followed by dropping the phospholipids on the surface of bu¡er to
form monomolecular lipid layer, which gave the desired initial surface
pressure. After the initial surface pressure stabilized to a plateau val-
ue, the appropriate amount of protein was injected to the mixing
chamber with a magnetic stir bar through a 0.7 cm2 hole in the
edge. Then the samples rapidly di¡used to the monolayer-spreading
disk to make an increase of the surface pressure. All measurements
were performed at room temperature.
2.6. Fluorescence measurement
Fluorescence measurements were carried out with a Hitachi F-4500
£uorescence spectrophotometer at 30‡C. PM, that normally modi¢es
cysteine residues, was employed to derivatize tBid. Brie£y, tBid was
dialyzed exhaustively against Tris bu¡er (20 mM Tris^HCl, pH 7.5,
50 mM NaCl) before chemical modi¢cation. Protein was modi¢ed at a
molar ratio of 3 mol of PM to 1 mol tBid for 2 h at 30‡C. After the
reaction, the protein sample was dialyzed against Tris bu¡er (20 mM
Tris^HCl, pH 7.5, 50 mM NaCl). The £uorescence intensity of PM-
labeled tBid with indicated liposomes was measured with excitation
and emission wavelength at 340 and 376 nm, respectively. Slits of 2.5
nm were used.
Fluorescence quenching was carried out with nitroxide spin-labeled
12-doxyl phosphatidylcholine (12-DPC). 12-DPC was incorporated
into the SUVs at a concentration of 10% (molar percent). Aliquots
of SUVs with or without 12-DPC were added to the cuvette contain-
ing PM-labeled tBid (1 WM). Fluorescence intensities in the absence
(F0) and the presence (F) of 12-DPC were corrected by subtracting
intensities measured without protein. The F0/F values were obtained
from the corrected spectra.
3. Results
3.1. Leakage of FITC-dextrans from LUVs
It has been reported that cardiolipin provides speci¢city for
targeting tBid to mitochondria and then e⁄ciently facilitates
the release of cytochrome c [14]. Herein, tBid-induced leakage
of FITC-dextran (FD-20) from LUVs composed of CL/
DOPC, DOPA/DOPC or DOPG/DOPC, at ratios 1:2 (mol:
mol), was studied and compared. As shown in Fig. 1A, tBid
induced the leakage to a larger extent in LUVs containing
cardiolipin than in those containing DOPA and DOPG.
Thus, cardiolipin is important not merely for the membrane
targeting of tBid, but also for its permeabilization function.
Also, leakage has been studied as a function of constant tBid
concentration and lipid concentration with LUVs composed
of CL/DOPC (1:2 molar ratio). When lipid concentration was
held constant, increasing amount of tBid induced a greater
extent of leakage until a plateau value was reached (Fig.
1A). With constant tBid concentration at 1 WM, increasing
the lipid concentration led to a decrease of leakage (Fig.
1B). Since increasing the lipid concentration increased the
number of vesicles in the suspension, the results were consis-
tent with the hypothesis that a de¢ned number of proteins is
required for the pore formation in bilayer.
To clarify the possible mechanism by which tBid permeates
the liposomes, we studied the leakage induced by tBid from
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the LUVs encapsulated with FITC-dextrans of di¡erent mo-
lecular weights. The molecular diameters of three FITC-dex-
trans, FD-20 (MW=21 200 Da), FD-70 (MW=71 600 Da)
and FD-250S (MW=282 000 Da), were measured by Dynao-
Pro LSR-TC. The measurements showed that the molecular
diameters increased correspondingly with the molecular
weights of FITC-dextrans. The tBid-induced leakage of FD-
20, FD-70 and FD-250S separately encapsulated in LUVs
composed of cardiolipin and DOPC (with molar ratio 1:2)
was assayed. The results revealed that the leakage extent of
FD-20 was higher than that of either FD-70 or FD-250S (Fig.
1C). These results suggest that the mechanism of the forma-
tion of discrete pores might be involved in the leakage process
as well, since the leakage e⁄ciency of markers with di¡erent
molecular weights would be the same if these results were due
to the carpet-like mechanism [20].
3.2. The e¡ect of phosphatidylethanolamine (PE) on the
leakage
PE is abundant on the outer mitochondrial membrane. To
investigate if PE will a¡ect the tBid-induced leakage, the e⁄-
ciency of leakage of FD-20 from LUVs made of CL/DOPC
(1:2 molar ratio) and CL/DOPC/DOPE (1:1:1 molar ratio)
were compared. Notably, the presence of DOPE decreased the
leakage of FD-20 from LUVs (Fig. 2A). CL and DOPE are
both known as non-lamellar phase phospholipids. To exclude
the possible e¡ect of non-bilayer-forming tendency of CL,
liposomes containing DOPG combined with di¡erent percen-
tages of DOPE were used in the further leakage assays. As
shown in Fig. 2B, DOPE caused a clear drop of tBid-induced
leakage of FD-20 from DOPG-containing LUVs, and with its
content increasing, the leakage e⁄ciency was gradually re-
duced. Furthermore, DEPE, without the non-bilayer-forming
tendency, was tested (Fig. 2C). Very interestingly, similar to
DOPE, the presence of DEPE lowered FD-20 leakage from
the DOPG-containing LUVs. Higher proportions of DEPE
led to lower leakage e⁄ciency. These results resembled those
obtained from the pore-forming peptides such as GALA or
magainin-2, which were similarly a¡ected by DOPE [23,24].
3.3. The insertion ability of tBid into phospholipid monolayer
An increase in the surface pressure is observed when a
protein is inserted into the phospholipid monolayer. Usually,
an increase of the surface pressure vZ is measured as a func-
tion of the initial surface pressure (Z). A plot of vZ versus Z
yields a straight line with a negative slope that intersects the
abscissa at the value named as the limiting surface pressure Zc.
The higher Zc value means stronger penetration ability of
protein. In monolayer, the ‘equivalence pressure’ of the bi-
layer may be de¢ned as the pressure at which the lipid density
in the monolayer is identical to that in the bilayer. The bilayer
equivalence pressure of the monolayer is thought to be 32^35
6
Fig. 1. tBid-induced leakage of FITC-dextrans from LUVs. tBid
was incubated with indicated LUVs encapsulated with FITC-dex-
trans. After an incubation at 30‡C for 30 min, centrifugation was
carried out at 35 000 rpm for 25 min at 4‡C. The FITC-dextrans re-
lease from LUVs was detected by £uorescence analysis of the super-
natant and pellet from each sample using a Hitachi F-4010 spectro-
£uorometer. A: Increasing amount of tBid was incubated with
LUVs at constant concentration 100 WM and induced the release of
FD-20 from LUVs composed of CL/DOPC, DOPA/DOPC or
DOPG/DOPC, at ratios 1:2 (mol:mol). B: E¡ect of lipid concentra-
tion on the leakage e⁄ciency of LUVs was assayed. The tBid con-
centration was kept constant at 1 WM while the concentration of
LUVs composed of CL/DOPC (1:2 molar ratio) was varied to ob-
tain the desired ratio. C: tBid induced the release of FITC-dextrans
with various molecular diameters (FD-20, FD-70, FD-250S) from
LUVs composed of CL/DOPC (1:2 molar ratio).
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mN/m [25], hence the Zc is a more in£uential factor in pre-
dicting the insertion ability of a protein into the membrane.
As shown in Fig. 3A, the penetration ability of tBid in
acidic phospholipids CL, DOPA or DOPG was comparable,
but was higher than in either DOPE or DOPC. The Zc of tBid
in CL, DOPG and DOPA was 42, 43 and 45 mN/m, respec-
tively, while for DOPE and DOPC, the Zc value was 37 and
28 mN/m, respectively. The results revealed that tBid has
more potential to insert into acidic phospholipid membranes,
but showed less insertion into neutral phospholipid DOPC or
DOPE. That is, the acidic phospholipid was necessary for the
insertion of tBid into lipid monolayer. Prior studies had pro-
posed that Bcl-XL could interact with the BH3 domain of Bid
through its hydrophobic cleft to prevent the leakage induced
by Bid [7]. Herein, the Zc value of tBid penetrating into phos-
pholipid monolayer was diminished when Bcl-XL was added
Fig. 3. Insertion of tBid into phospholipid monolayer. Relations be-
tween the initial surface pressure and the surface pressure increase
were detected. A: Displayed were the Z^vZ plots of surface pressure
changes after injection of tBid (0.5 Wg/ml) underneath indicated
phospholipid monolayer at di¡erent initial surface pressures. The
limiting pressures of tBid in CL, DOPA, DOPG, DOPE and DOPC
were 42, 45, 43, 37 and 28 mN/m, respectively. B: Bcl-XL func-
tioned as an inhibitor of tBid inserting into phospholipid mono-
layer. The limiting pressure of tBid reduced when Bcl-XL was
present.
Fig. 2. The e¡ect of PE on the leakage. A: E¡ect of increasing
amount of tBid on the leakage of FD-20 from 100 WM LUVs
of CL/DOPC (1:2 molar ratio) and CL/DOPC/DOPE (1:1:1 molar
ratio). B, C: In the LUVs composed of DOPG/DOPC/DOPE or
DOPG/DOPC/DEPE, the fraction of DOPG was kept constant
and the content of DOPE or DEPE changed from 10, 30 to 50
mol%. The £uorescence intensity of FD-20 leaking from indicated
LUVs with increasing tBid amount was detected as described in
Section 2.
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(Fig. 3B), which indicated that the interaction of tBid with
Bcl-XL prevented its further insertion into the membrane.
3.4. Penetration of tBid into acidic phospholipid vesicles
To further study tBid insertion into phospholipid bilayers,
the environmentally sensitive pyrene (PM) probe was used as
a positional marker of tBid. By virtue of its chemical speci¢c-
ity toward sulfhydryl group [26], PM could be an ideal can-
didate to probe the free sulfhydryl group Cys-126 in the H5
helical region of tBid. Fig. 4A shows that the £uorescence
intensity increased when CL-containing vesicles were intro-
duced to PM-labeled tBid, which implied the penetration of
the protein into the hydrophobic region of the membrane.
Furthermore, changes in the £uorescence intensities of PM-
labeled tBid following its interaction with various phospholip-
id vesicles were measured (Fig. 4B). The results revealed that,
in accordance with the studies of the phospholipid monolayer,
tBid could penetrate into the membrane bilayer made of CL,
DOPA or DOPG, but not of DOPC or DOPE.
Moreover, the location of the PM-labeled cysteine residue
with respect to the phospholipid membranes was determined
by £uorescence quenching with spin-labeled derivatives of
phosphatidylcholine (PC). 12-DPC contains a doxylstearate
labeled at carbon-12 of the fatty acid in PC, and this chemical
side group quenches PM £uorescence, which is primarily static
rather than collisional. Only when the doxyl moiety buried
within the membrane bilayer is no more than 5 AU from
PM-labeled cysteine can the £uorescence of PM be e⁄ciently
quenched [27]. Fig. 4C showed that the £uorescence intensity
of the PM-labeled cysteine was sharply decreased by 12-DPC.
This result indicated that tBid had the intrinsic potential to
penetrate deeply into acidic phospholipid membranes rather
than at a super¢cially shallow location.
4. Discussion
As a member of the BH3 domain only subset of Bcl-2
family, Bid is involved in various pathways of apoptosis
that interplay the activation of caspases with mitochondrial
dysfunction. A convergence of biochemical and cellular stud-
ies was committed to investigate the mechanism by which Bid
acts on mitochondrial membranes [7,28]. To address this ques-
tion, model membranes with de¢nite compositions had been
constructed to resemble the interaction of tBid with mitochon-
drial membranes, leading to cytochrome c release from mito-
chondria. A crucial point for understanding the interaction of
tBid with model membranes is the determination of the pos-
sible mechanism of leakage. Through extensive studies on
amphipathic K-helical peptides, researchers had proposed
two general mechanisms underlying the release of entrapped
probes: transmembrane pore formation with a barrel stave
mechanism and membrane destruction with a carpet-like
mechanism [20].
In this study, we used the £uorescent dextrans with various
molecular diameters as the markers to test the leakage pro-
moted by tBid in the model membrane systems. As shown in
Fig. 1, following the action of tBid on the LUVs, FD-20, due
to its smaller molecular diameter, released at a greater extent
from LUVs than FD-70 or FD250S; tBid was more e¡ective
in promoting leakage of FITC-dextrans from LUVs com-
posed of CL and DOPC compared with LUVs made of
DOPA or DOPG and DOPC. This pertinency of the leakage
Fig. 4. Demonstration of tBid penetrating into acidic phospholipid
vesicles. A: Fluorescence spectra of PM-labeled tBid before and
after vesicles of CL were added. The £uorescence spectra were
monitored with excitation wavelength at 340 nm and emission from
360 to 500 nm. B: The relative £uorescence intensity of PM-tBid
was assayed as a function of the ratio of liposomes/PM-tBid (molar
ratio) with various phospholipid vesicles. C: Quenching of PM-la-
beled tBid £uorescence by 12-DPC. 1 WM PM-tBid was added to in-
dicated phospholipid vesicles with or without 12-DPC. F0 and F
represent the £uorescence intensities measured using PM-tBid/phos-
pholipid vesicles in the absence or presence of 12-DPC, respectively.
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e⁄ciency to the molecular diameters of £uorescent markers
meant that discrete pores might be formed by the protein after
its interaction with membranes. Otherwise, markers with dif-
ferent molecular weights would have released with the same
e⁄ciency if the carpet-like mechanism functioned [20,29]. In
the leakage assay, with tBid concentration kept constant, in-
creasing the lipid concentration resulted in a decrease in the
extent of leakage, while decreasing the amount of tBid led to a
reduction in leakage. This ¢nding was also consistent with a
monomer^multimer assembly pore-forming process. The
pore-forming behavior of tBid in membranes might be ac-
countable for the leakage of apoptotic factors from mitochon-
dria, with molecular weights ranging from 14 kDa (cyto-
chrome c) to 57 kDa (AIF) [5,30^32]. Moreover,
displacement of DOPC by DOPE or DEPE decreased the
leakage, and the leakage e⁄ciency was further reduced with
increasing amount of DOPE or DEPE in the membranes (Fig.
2). Notably, this phenomenon was also observed in the case of
the pore-forming peptides such as GALA or magainin-2
[23,24]. It has been suggested that PE, with a smaller head-
group, would stabilize the surface state of proteins and hence
reduce the protein insertion and subsequently pore formation
[23]. This may account for our observation, further suggesting
the pore-forming behavior of tBid. It is worthy to note that
DOPE, characterized with non-lamellar phase tendency,
showed no prompting e¡ect on the action of tBid on the
membrane in our observations. Thus, it can be questioned
why CL, also known for its non-lamellar phase tendency,
showed the speci¢c role in tBid-induced leakage compared
to DOPA and DOPG. This special property of CL in the
interaction with tBid deserves further investigation to shed
light on its biological roles.
The pore-forming mechanism involves three distinct steps.
First, monomers bind to the membrane; second, these mono-
mers insert into the hydrophobic core of the lipid bilayer; and
¢nally, pores form in the membranes. To investigate if tBid
actually inserted into the hydrophobic core of the membrane,
the phospholipid monolayer assay and £uorescence quenching
measurement were carried out (Figs. 3 and 4). The data
showed that tBid did insert deeply into the hydrophobic
acyl chain of acidic phospholipids, rather than merely binding
at the surface of LUVs or being located at a super¢cially
shallow position.
Recent studies showed that the insertion of tBid into the
mitochondrial membrane might cause a conformational
change, such as the exposure of hydrophobic domains that
were previously buried, that enabled oligomerization of tBid
[19]. Moreover, the three-dimensional structure and the in
vitro electrophysiological data also suggested tBid as a pore-
forming protein [11,17,18]. Through model membrane studies,
we tentatively proposed that tBid could penetrate into the
hydrophobic core of the membrane, resulting in the leakage
of entrapped FITC-dextrans from LUVs more likely by a
pore-forming mechanism. It can further be speculated that
tBid oligomers might form pores in the mitochondrial mem-
brane. More evidence in vivo is also required to clarify the
rationality of this model. Related studies are still in progress.
Acknowledgements: This work was ¢nancially supported by grants
from the National Natural Science Foundation of China and the
Chinese Academy of Sciences. We thank Dr. Xiaodong Wang, De-
partment of Biochemistry, University of Texas Southwestern Medical
Center, Dallas, TX, USA for the generous gift of caspase 8 expression
plasmids. We thank Dr. Bruno Antonsson, Serono Pharmaceutical
Research Institute, Switzerland for the murine Bid expression plas-
mid. We are grateful for the assistance of Yunfeng Li in the phos-
pholipid monolayer assay.
References
[1] Green, D.R. and Reed, J.C. (1998) Science 281, 1309^1312.
[2] Wang, X.D. (2001) Genes Dev. 15, 2922^2933.
[3] Adams, J.M. and Cory, S. (1998) Science 281, 1322^1326.
[4] Antonsson, B. and Martinou, J.C. (2000) Exp. Cell Res. 256, 50^
57.
[5] Luo, X., Budihardjo, I., Zou, H., Slaughter, C. and Wang, X.
(1998) Cell 94, 491^501.
[6] Li, H., Zhu, H., Xu, C.J. and Yuan, J. (1998) Cell 94, 491^501.
[7] Wei, M.C., Lindsten, T., Mootha, V.K., Weiler, S., Gross, A.,
Ashiya, M., Thompson, C.B. and Korsmeyer, S.J. (2000) Genes
Dev. 14, 2060^2071.
[8] Werner, A., de Vries, E., Tait, S.W., Bontjer, I. and Borst, J.
(2002) J. Biol. Chem. 277, 22781^22788.
[9] Kudla, G., Montessuit, S., Eskes, R., Berrier, C., Martinou, J.C.,
Ghazi, A. and Antonsson, B. (2000) J. Biol. Chem. 275, 22713^
22718.
[10] Epand, R., Martinou, J.C., Fornallaz-Mulhauser, M., Hughes,
D. and Epand, R. (2002) J. Biol. Chem. 277, 32632^32639.
[11] Schendel, S.L., Azimov, R., Pawlowski, K., Godzik, A., Kagan,
B.L. and Reed, J.C. (1999) J. Biol. Chem. 274, 21932^21936.
[12] Zhai, D., Huang, X., Han, X. and Yang, F. (2000) FEBS Lett.
472, 293^296.
[13] Zhai, D., Miao, Q., Xin, X. and Yang, F. (2001) Eur. J. Bio-
chem. 268, 48^55.
[14] Lutter, M., Fang, M., Luo, X., Nishijima, M., Xie, X.S. and
Wang, X. (2000) Nat. Cell. Biol. 2, 754^756.
[15] Esposti, M., Erler, J., Hickman, J. and Dive, C. (2001) Mol. Cell.
Biol. 21, 7268^7276.
[16] Esposti, M. (2002) Biochim. Biophys. Acta 1553, 331^340.
[17] Chou, J.J., Li, H., Salvesen, G.S., Yuan, J. and Wagner, G.
(1999) Cell 96, 615^624.
[18] McDonnell, J.M., Fushman, D., Milliman, C.L., Korsmeyer, S.J.
and Cowburn, D. (1999) Cell 96, 625^634.
[19] Grinberg, M., Sarig, R., Zaltaman, Y., Frumkin, D., Grammma-
tikakis, N., Reuveny, E. and Gross, A. (2002) J. Biol. Chem. 277,
12237^12245.
[20] Shai, Y. (1999) Biochim. Biophys. Acta 1462, 55^70.
[21] Rouser, G., Fleischer, S. and Yamamoto, A. (1970) Lipids 5,
494^496.
[22] Miao, Q., Han, X. and Yang, F. (2001) Biochem. J. 354, 681^
688.
[23] Nicol, F., Nir, S. and Szoka, F. (2000) Biophys. J. 78, 818^829.
[24] Matsuzaki, K., Sugishita, K., Ishibe, N., Ueha, M., Nakata, S.,
Miyajima, K. and Epand, R. (1998) Biochemistry 37, 11856^
11863.
[25] Burger, K.N., Denel, R.A. and de Kruij¡, B. (1998) Biochemistry
37, 12588^12595.
[26] Barrantes, F., Antollin, S., Blanton, M. and Prieto, M. (2000)
J. Biol. Chem. 275, 37333^37339.
[27] Chattopadhyay, A. and London, E. (1987) Biochemistry 26, 39^
45.
[28] Crompton, M. (2000) Curr. Opin. Cell Biol. 12, 414^419.
[29] Butko, P., Huang, F., Pusztai-Carey, M. and Surewicz, W. (1996)
Biochemitry 35, 11355^11360.
[30] Chai, J., Du, C., Wu, J., Kyin, S., Wang, X. and Shi, Y. (2000)
Nature 406, 855^862.
[31] Li, L., Luo, X. and Wang, X. (2001) Nature 412, 95^99.
[32] Susin, S., Lorenzo, H., Zamzami, N., Marzo, I., Snow, B., Broth-
ers, G., Mangion, J., Jacoto, E., Costantini, P., Loe¥er, M.,
Larochette, N., Goodlett, D., Aebersold, R., Siderovski, D., Pen-
ninger, J. and Kroemer, G. (1999) Nature 397, 441^445.
FEBS 27908 3-12-03
L. Yan et al./FEBS Letters 555 (2003) 545^550550
